Detailed Description
Various exemplary embodiments of the invention will now be described in detail, which should not be considered as limiting the invention, but rather as more detailed descriptions of certain aspects, features and embodiments of the invention.
Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Although only preferred methods and materials are described herein, any methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present invention. All documents mentioned in this specification are incorporated by reference for the purpose of disclosing and describing the methods and/or materials associated with the documents. In case of conflict with any incorporated document, the present specification will control.
It will be apparent to those skilled in the art that various modifications and variations can be made in the specific embodiments of the invention described herein without departing from the scope or spirit of the invention. Other embodiments will be apparent to those skilled in the art from consideration of the specification of the present invention. The specification and examples of the present invention are exemplary only.
As used herein, the terms "comprising," "including," "having," "containing," and the like are intended to be inclusive and mean an inclusion, but not limited to.
The materials and reagents involved in the following examples are as follows:
Coli ESCHERICHIA COLI HST, bacillus subtilis Bacillus subtilis RIK1285, and bacillus subtilis expression vector pBE-S were all purchased from baori doctor technology (beijing) inc.
KOD-Plus-neo DNA polymerase from Toyobo Co., ltd., DNA restriction endonuclease from FERMENTASE, PCR product purification kit, plasmid extraction kit E.Z.N.A. from Omega Bio-tek Co., clonExpressUltra One Step Cloning Kit kit is purchased from Nanjinouzan Biotechnology Co., ltd, CHELATING SEPHAROSETM FAST FLOW from U.S. GE HEALTHCARE, bradford method protein concentration determination kit is purchased from Shanghai Biotechnology Co., ltd, high activity yeast is purchased from Angel Yeast Co., ltd, gene synthesis is completed by Shanghai Bo Biotechnology Co., ltd, polymerase chain reaction primer synthesis and sequencing is completed by Shanghai Biotechnology Co., ltd, and other chemical reagents are all domestic or imported analytical pure.
LB medium (g/L) tryptone 10, yeast extract 5, naCl 10, pH 7.0. The screening medium used was LB medium containing 100. Mu.g/mL ampicillin and LB medium containing 10. Mu.g/mL kanamycin.
The molecular cloning techniques and protein detection techniques used in the present invention are conventional in the art. The techniques not described in detail in the examples below are all carried out according to the relevant parts of the following laboratory manuals :Green M R,SambrookJ.Molecular cloning:alaboratory manual[M].NewYork:Cold Spring Harbor Laboratory Press,2012.
EXAMPLE 1 construction of Phytase-pullulanase fusion proteins
1. Synthesis of Gene
The gene sequence of the phytase YiAPPA from YERSINIA INTERMEDIA is shown as SEQ ID NO.1, the amino acid sequence is shown as SEQ ID NO.2, the gene sequence of the pullulanase TK-PUL from Thermococcus kodakarensis is shown as SEQ ID NO.3, the amino acid sequence is shown as SEQ ID NO.4, the gene sequence of the connecting peptide L1 is shown as SEQ ID NO.5, the amino acid sequence is shown as SEQ ID NO.6, the gene sequence of the connecting peptide L2 is shown as SEQ ID NO.7, the amino acid sequence is shown as SEQ ID NO.8, the gene sequence of the connecting peptide L3 is shown as SEQ ID NO.9, the amino acid sequence is shown as SEQ ID NO.10, the gene sequence of the connecting peptide L4 is shown as SEQ ID NO.11, and the amino acid sequence is shown as SEQ ID NO. 12. The genes are delivered to Shanghai Bo Yi Biotechnology Co.Ltd for complete gene synthesis.
SEQ ID NO.1:
AATAGTTATGCGATTAGTGCCGCGCCGGTTGCCATACAACCCACGGGCTATACATTGGAGCGAGTGGTTATTTTGAGCCGCCATGGTGTTCGCTCGCCAACCAAACAAACACAGTTAATGAATGATGTTACCCCTGACACGTGGCCGCAATGGCCGGTCGCCGCAGGATACTTAACCCCCCGAGGTGCACAATTAGTGACATTGATGGGCGGATTCTATGGTGATTACTTCCGTAGCCAAGGGTTACTCGCAGCAGGGTGCCCAACTGACGCGGTTATTTATGCTCAGGCCGATGTTGATCAACGAACGCGTTTAACGGGGCAGGCATTCCTTGATGGAATAGCACCGGGGTGTGGACTGAAAGTACATTATCAGGCTGATTTGAAAAAAGTGGATCCGCTGTTTCATCCCGTCGACGCGGGGGTGTGTAAGTTAGATTCGACACAAACCCATAAGGCTGTTGAGGAGCGACTAGGTGGGCCATTAAGTGAACTGAGCAAACGCTATGCTAAGCCCTTTGCCCAGATGGGTGAGATTCTGAATTTTGCGGCATCTCCTTACTGTAAATCACTGCAACAGCAAGGGAAAACCTGTGATTTTGCCAACTTTGCAGCGAATAAGATCACGGTGAACAAGCCGGGGACAAAAGTCTCGCTCAGCGGACCACTGGCACTGTCATCAACCTTAGGTGAGATCTTTTTGCTACAAAATTCACAAGCGATGCCTGATGTTGCCTGGCATCGGTTAACGGGAGAAGATAATTGGATCTCGTTATTATCGTTGCACAATGCGCAATTTGATTTAATGGCAAAAACACCTTATATCGCTCGTCATAAGGGCACACCGTTGCTGCAACAGATCGAGACTGCCCTCGTCCTTCAGCGTGATGCTCAGGGGCAAACATTGCCATTATCACCTCAAACCAAAATTCTGTTCCTCGGGGGACATGATACAAACATCGCCAATATTGCTGGAATGTTGGGGGCTAACTGGCAATTACCACAGCAGCCCGATAATACCCCACCTGGGGGGGGATTGGTCTTCGAGCTATGGCAAAACCCAGATAATCATCAACGTTATGTCGCGGTGAAAATGTTCTATCAAACAATGGGCCAATTGCGAAATGCTGAGAAACTAGACCTGAAAAACAATCCGGCTGGTAGGGTCCCTGTTGCAATAGACGGTTGTGAAAATAGTGGTGATGACAAACTTTGTCAGCTTGATACCTTCCAAAAGAAAGTAGCTCAGGCGATTGAACCTGCTTGCCATATT.
SEQ ID NO.2:
NSYAISAAPVAIQPTGYTLERVVILSRHGVRSPTKQTQLMNDVTPDTWPQWPVAAGYLTPRGAQLVTLMGGFYGDYFRSQGLLAAGCPTDAVIYAQADVDQRTRLTGQAFLDGIAPGCGLKVHYQADLKKVDPLFHPVDAGVCKLDSTQTHKAVEERLGGPLSELSKRYAKPFAQMGEILNFAASPYCKSLQQQGKTCDFANFAANKITVNKPGTKVSLSGPLALSSTLGEIFLLQNSQAMPDVAWHRLTGEDNWISLLSLHNAQFDLMAKTPYIARHKGTPLLQQIETALVLQRDAQGQTLPLSPQTKILFLGGHDTNIANIAGMLGANWQLPQQPDNTPPGGGLVFELWQNPDNHQRYVAVKMFYQTMGQLRNAEKLDLKNNPAGRVPVAIDGCENSGDDKLCQLDTFQKKVAQAIEPACHI.
SEQ ID NO.3:
AGCGGATGTATCTCGGAGAGCAACGAAAATCAAACTGCAACGGCTTCGACCGTTCCACCGACTTCAGTGACACCCTCACAGTCTTCCACTCCCACAACCTCGACCTCGACGTACGGCCCTTCCGAAAGAACGGAGCTTAAACTTCCTTCGGTTAACTACACTCCCATCTACGTCGGCATAGAGAAAGGCTGTCCCTCCGGAAGAGTCCCGGTGAAGTTCACGTACAACCCCGGAAACAAGACCGTAAAGTCTGTCAGCCTCCGCGGGAGCTTCAACAACTGGGGAGAGTGGCCGATGGAGCTGAAGAACGGCACGTGGGAGACGACCGTCTGTCTCCGCCCTGGAAGGTATGAGTATAAGTACTTCATCAACGGCCAGTGGGTCAAGGACATGTCCGACGACGGGACGGGAAGGCCCTACGACCCCGATGCAGACGCCTATGCCCCCGATGGCTACGGGGGAAAGAACGCCGTGAGGGTAGTTGAGGGCCGCGAAGCGTTCTACGTGGAGTTCGATCCAAGAGACCCAGCCTACCTCAGCATCGCGGACAAAAGAACCGTGGTCAGGTTCGAGGCTAAGAGAGACACCGTCGAGTCTGCGGTTCTCGTTACGGATCACGGGAACTACACGATGAAGCTTCAGGTCTGGTGGGACTTCGGCGAAACCTGGCGCGCCGAGATGCCAGTTGAACCCGCTGATTATTACATTCTCGTAACCTCCTCCGACGGCGGGAAGTTTGCCGTCCTAAACACAAGCGAAAGCCCGTTCTTCCACTTTGATGGCGTTGAGGGGTTCCCCCAGCTGGAGTGGGTGAGCAACGGGATAACCTACCAGATATTCCCCGACAGGTTCAACAACGGCAATAAAAGCAACGATGCCCTAGCTTTGGATCACGACGAGCTAATTTTGAACCAGGTTAATCCAGGGCAGCCAATCCTCTCCAACTGGAGCGACCCGATAACGCCCCTCCACTGCTGCCACCAGTACTTCGGCGGCGACATAAAGGGAATAACGGAGAAGCTCGACTACCTTCAGAGCCTAGGTGTTACTATAATCTACATCAACCCGATTTTCCTCTCGGGAAGCGCCCACGGCTACGACACCTACGACTACTACCGGCTCGACCCCAAGTTCGGGACCGAGGATGAGCTGAGAGAGTTCCTCGATGAGGCCCACAGGAGGGGAATGAGGGTAATCTTCGATTTCGTGCCCAACCACTGCGGCATAGGGAATCCAGCCTTCCTCGACGTCTGGGAGAAGGGCAACGAAAGCCCATACTGGGACTGGTTCTTCGTCAAGAAGTGGCCCTTCAAGCTCGGCGATGGGAGCGCCTACGTCGGCTGGTGGGGCTTTGGGAGCCTTCCGAAGCTCAACACTGCCAACCAGGAGGTCAGGGAGTACCTGATAGGAGCGGCCCTCCACTGGATAGAGTTCGGCTTTGACGGCATTAGGGTGGATGTGCCGAACGAAGTCCTCGACCCGGGGACGTTCTTCCCGGAGCTGAGAAAGGCAGTTAAGGAGAAAAAGCCCGACGCGTACCTCGTCGGCGAGATATGGACGCTCTCCCCGGAGTGGGTGAAGGGAGACCGCTTCGACTCCCTCATGAACTACGCCCTCGGGAGGGACATCCTCCTGAACTACGCTAAGGGCCTGCTCAGCGGAGAAAGTGCAATGAAAATGATGGGACGTTACTACGCTTCCTACGGCGAGAACGTAGTTGCGATGGGCTTCAACCTCGTTGATTCGCACGACACTTCGAGGGTTCTCACTGACCTCGGTGGTGGCAAACTGGGAGACACACCGTCAAACGAGTCAATTCAGAGGCTCAAGCTCCTCTCAACGCTCCTCTATGCCCTGCCCGGAACTCCCGTCACCTTCCAGGGGGACGAGAGGGGACTGCTCGGAGACAAGGGACACTACGATGAGCAACGCTATCCGATACAGTGGGATACTGTGAACGAGGACGTCCTGAACCACTACAGGGCACTGGCGGAGCTCAGAAAAAGAGTTCCCGCATTGAGGAGCAGCGCAATGAGGTTCTACACTGCCAAAGGCGGCGTTATGGCCTTCTTCAGGGGACATCATGACGAGGTTCTCGTCGTTGCCAACAGCTGGAAGAAGCCAGCCCTACTGGAGCTTCCCGAGGGAGAGTGGAAAGTAATCTGGCCTGAGGATTTCAGCCCGGAACTGCTTCGCGGCACAGTTGAAGTGCCAGCCATAGGGATAATCATCCTTGAGCGGGGT.
SEQ ID NO.4:
SGCISESNENQTATASTVPPTSVTPSQSSTPTTSTSTYGPSERTELKLPSVNYTPIYVGIEKGCPSGRVPVKFTYNPGNKTVKSVSLRGSFNNWGEWPMELKNGTWETTVCLRPGRYEYKYFINGQWVKDMSDDGTGRPYDPDADAYAPDGYGGKNAVRVVEGREAFYVEFDPRDPAYLSIADKRTVVRFEAKRDTVESAVLVTDHGNYTMKLQVWWDFGETWRAEMPVEPADYYILVTSSDGGKFAVLNTSESPFFHFDGVEGFPQLEWVSNGITYQIFPDRFNNGNKSNDALALDHDELILNQVNPGQPILSNWSDPITPLHCCHQYFGGDIKGITEKLDYLQSLGVTIIYINPIFLSGSAHGYDTYDYYRLDPKFGTEDELREFLDEAHRRGMRVIFDFVPNHCGIGNPAFLDVWEKGNESPYWDWFFVKKWPFKLGDGSAYVGWWGFGSLPKLNTANQEVREYLIGAALHWIEFGFDGIRVDVPNEVLDPGTFFPELRKAVKEKKPDAYLVGEIWTLSPEWVKGDRFDSLMNYALGRDILLNYAKGLLSGESAMKMMGRYYASYGENVVAMGFNLVDSHDTSRVLTDLGGGKLGDTPSNESIQRLKLLSTLLYALPGTPVTFQGDERGLLGDKGHYDEQRYPIQWDTVNEDVLNHYRALAELRKRVPALRSSAMRFYTAKGGVMAFFRGHHDEVLVVANSWKKPALLELPEGEWKVIWPEDFSPELLRGTVEVPAIGIIILERG.
SEQ ID NO.5:GAGGGTAAGTCTTCGGGCTCAGGCTCAGAGTCAAAATCCACC。
SEQ ID NO.6:EGKSSGSGSESKST。
SEQ ID NO.7:GGTTCCGCTGGATCAGCTGCTGGATCAGGAGAATTC。
SEQ ID NO.8:GSAGSAAGSGEF。
SEQ ID NO.9:
GCTGAAGCTGCTGCTAAGGAAGCTGCTGCTAAGGAAGCTGCTGCTAAGGCT。
SEQ ID NO.10:AEAAAKEAAAKEAAAKA。
SEQ ID NO.11:
GAAGCTGCTGCTAAGGAAGCTGCTGCTAAGGGTGGTGGTGGTTCCGGTGGTGGTGGTTCCGGTG GTGGTGGTTCC。
SEQ ID NO.12:EAAAKEAAAKGGGGSGGGGSGGGGS。
2. Construction of recombinant expression plasmid for Phytase YiAPPA and recombinant expression plasmid for pullulanase TK-PUL
PCR was performed by designing a PCR primer Y-F, Y-R (Table 1) based on the gene sequence of phytase YiAPPA, using the synthetic gene of YiAPPA as a template and Y-F, Y-R as a primer. The PCR amplification system was 10 Xbuffer I5. Mu. L, dNTP. Mu. L, mgSO 4. Mu.L, 2. Mu.L of each of the upstream and downstream primers, and 2. Mu. L, ddH 2 O28. Mu.L of the template 1. Mu. L, KOD-Plus-neo DNA polymerase. The PCR amplification conditions were 98℃for 5min, 98℃for 20s,60℃for 40s,74℃for 2min,30 cycles, and 74℃for 10min. The amplified product was digested with NdeI and XbaI, ligated into vector pBE-S digested with the same double digestion, and recombinant plasmid pBE-S-yiappa was constructed.
PCR primers T-F, T-R (Table 1) were designed based on the gene sequence of the pullulanase TK-PUL, and PCR amplification was performed using the synthetic gene of TK-PUL as a template and T-F, T-R as a primer. The PCR amplification system is the same as above. The PCR amplification conditions were 98℃for 5min, 98℃for 20s,60℃for 40s,74℃for 2min for 10 s,30 cycles, and 74℃for 10min. The amplified product was digested with NdeI and XbaI, ligated into vector pBE-S digested with the same double digestion, and recombinant plasmid pBE-S-tkpul was constructed.
TABLE 1 primers for construction of recombinant plasmids
| Primer name |
Primer sequences |
| Y-F |
5’-GCACATATGAATAGTTATGCGATTAGTG-3’(SEQ ID NO.13) |
| Y-R |
5’-ATGTCTAGAAATATGGCAAGCAGGTTC-3’(SEQ ID NO.14) |
| T-F |
5’-GCACATATGAGCGGATGTATCTCGGAGAG-3’(SEQ ID NO.15) |
| T-R |
5’-ATGTCTAGAACCCCGCTCAAGGATG-3’(SEQ ID NO.16) |
Note that the underlined parts are restriction enzyme cleavage sites.
3. Construction of Phytase-pullulanase fusion proteins
The phytase-pullulanase fusion protein is constructed by adopting a protein fusion technology, and the construction schematic diagram is shown in figure 1. According to ClonExpressUltra One Step Cloning Kit kit instructions and primers required for designing each gene sequence (Table 2).
The construction steps of the fusion protein T-L1-Y are as follows:
(1) PCR primers TL1Y-F, TL Y-R (Table 2) were designed based on the gene sequence of vector pBE-S, and PCR amplification was performed using vector pBE-S as template and TL1Y-F, TL Y-R as primer to prepare linearized vector. Designing PCR primers according to the gene sequence of the fusion unit, carrying out PCR amplification by taking the synthetic gene of the pullulan hydrolase TK-PUL as a template, taking TL1Y-F1 and TL1Y-R1 as primers to prepare an insert fragment 1, taking the synthetic gene of the connecting peptide L1 as a template, taking TL1Y-F2 and TL1Y-R2 as primers to prepare an insert fragment 2, carrying out PCR amplification by taking the synthetic gene of the phytase YiAPPA as a template and taking TL1Y-F3 and TL1Y-R3 as primers to prepare an insert fragment 3. And purifying the PCR amplified product by using a PCR product purification kit. The PCR amplification system is the same as above. The PCR amplification conditions were 98℃for 5min, 98℃for 20s,60℃for 40s,74℃for 4min,30 cycles, and 74℃for 10min.
(2) Mixing the purified PCR amplified products according to ClonExpressUltra One Step Cloning Kit the kit instruction book configures a recombination reaction system. The recombination reaction system included 1. Mu.L of linearization vector, 12. Mu.L of insert, 20.5. Mu.L of insert, 31.5. Mu.L of insert, and 5. Mu.L of 2 XCE Mix. The recombination reaction condition is 50 ℃ for 30min. After the reaction is completed, the recombination reaction system is immediately placed on ice for cooling, and a recombination product composed of a linearization vector and 3 inserts is obtained.
(3) The recombinant product is transformed into escherichia coli HST08 competent cells, and ampicillin resistance plates are used for screening transformants, so as to extract recombinant plasmids. The recombinant plasmid was sent to Shanghai Bioengineering Co., ltd for sequencing and aligned with the corresponding gene sequence, confirming the success of construction of the recombinant plasmid pBE-S-tl1 y.
The construction method of the fusion protein T-L2-Y, T-L3-Y, T-L4-Y, Y-L1-T, Y-L2-T, Y-L3-T, Y-L4-T is carried out according to the construction method of the fusion protein T-L1-Y.
TABLE 2 primers for the construction of phytase-fusion proteins
Example 2 screening of Phytase-pullulanase fusion proteins
1. Expression of Phytase YiAPPA, pullulanase TK-PUL and Phytase-pullulanase fusion proteins
Recombinant expression plasmids of phytase YiAPPA, pullulanase TK-PUL and phytase-pullulanase fusion proteins are respectively transformed into bacillus subtilis RIK1285 competent cells, and pBE-S is transformed as negative control Contr to obtain recombinant bacillus subtilis.
The seed culture condition of the recombinant bacillus subtilis is that LB liquid medium containing 10 mug/mL kanamycin is adopted, and a 100mL triangular flask is used for culture, wherein the liquid loading amount of the medium is 10mL, the culture temperature is 37 ℃, the rotating speed is 180rpm, and the culture time is 24 hours. The fermentation culture condition of the recombinant bacillus subtilis is that LB liquid medium containing 10 mug/mL kanamycin is adopted, and a 500mL triangular flask is used for culture, wherein the liquid loading amount of the medium is 50mL, the inoculation amount is 1%, the culture temperature is 37 ℃, the rotating speed is 180rpm, and the culture time is 36h.
2. Purification of Phytase YiAPPA, pullulanase TK-PUL and Phytase-pullulanase fusion proteins
Purifying the target protein in the fermentation supernatant by adopting a Ni 2+ affinity chromatographic column, and eluting by using 200mmol/L imidazole elution buffer solution to obtain the purified fusion protein. Purity of the fusion protein was checked by SDS-PAGE and concentration of the fusion protein was determined by the Bradford method.
3. Screening of Phytase-pullulanase fusion proteins
Enzyme activity measurement of phytase, namely, 250 mu L of enzyme solution is taken in a centrifuge tube, 750 mu L of 0.25mol/L sodium acetate buffer solution (pH 4.5) is added, and the mixture is uniformly mixed. 2mL of 1.5mmol/L sodium phytate solution (0.25 mol/L sodium acetate buffer, pH 4.5) was added to the experimental tube, and 2mL of the color/end point mixture (ammonium molybdate/ammonium vanadate/nitric acid) was added to the control, and shaken well. Immediately after 30min of reaction at 30 ℃, 2mL of the color/endpoint mixture was added to the experimental group, 2mL of 1.5mmol/L sodium phytate solution was added to the control group, and the mixture was mixed well, and the light absorption value was measured at 415 nm. The conversion formula of the inorganic phosphorus content in the reaction solution and the absorbance of the reaction solution at 415nm is shown as follows, inorganic phosphorus (mmol/L) = 26.5510 ×OD 415nm +0.3113. The phytase activity unit (U) is defined as the amount of phytase required to release 1. Mu. Mol/L inorganic phosphorus from 1.5mmol/L sodium phytate solution per minute at 37℃ C, pH 4.5, as one enzyme activity unit (U). The results of the phytase activity assay of the phytase YiAPPA and phytase-pullulanase fusion proteins are shown in Table 3.
Measurement of the enzyme Activity of amylase 10. Mu.L of enzyme solution was mixed with 490. Mu.L of 50mmol/L MES containing 1% (m/v) wheat starch, pH 4.5 buffer, reacted at 30℃for 30min, and then rapidly placed in an ice-water bath to terminate the reaction, and then the amount of reducing sugar in the reaction system was measured by the 3, 5-dinitrosalicylic acid method. The resulting reducing sugars were converted to maltose mass representation by means of a maltose standard working curve. The enzyme activity unit (U) is defined as the amount of enzyme catalyzing the production of 1. Mu. Mol of maltose per minute under certain reaction conditions. The results of the amylase activity assay for the pullulanase TK-PUL and the phytase-pullulanase fusion protein are shown in Table 3.
The phytase activity and amylase activity measurement results of the phytase-pullulanase fusion protein show that the phytase specific activity of the fusion protein Y-L4-T is 1802.59U/mg, the phytase specific activity is basically consistent with that of phytase YiAPPA, the amylase specific activity of the fusion protein Y-L4-T is 60.94U/mg, and the phytase specific activity is improved by 1.42 times compared with that of pullulanase. SDS-PAGE detection of phytase YiAPPA, pullulanase TK-PUL and fusion protein Y-L4-T is shown in FIG. 2.
TABLE 3 enzyme Activity measurement of phytase-pullulanase fusion protein (37 ℃ C., pH 4.5)
| Recombinant proteins |
Specific activity of phytase (U/mg) |
Recombinant proteins |
Specific activity of amylase (U/mg) |
| YiAPPA |
1785.32±109.05 |
TK-PUL |
25.22±2.31 |
| T-L1-Y |
1053.33±100.26 |
T-L1-Y |
20.34±2.09 |
| T-L2-Y |
1089.53±109.03 |
T-L2-Y |
19.82±1.83 |
| T-L3-Y |
1389.51±110.68 |
T-L3-Y |
24.36±1.47 |
| T-L4-Y |
1492.16±134.15 |
T-L4-Y |
24.69±1.43 |
| Y-L1-T |
1391.23±119.02 |
Y-L1-T |
25.02±1.33 |
| Y-L2-T |
1433.15±128.25 |
Y-L2-T |
25.71±1.73 |
| Y-L3-T |
1675.26±154.04 |
Y-L3-T |
39.96±2.95 |
| Y-L4-T |
1802.59±128.27 |
Y-L4-T |
60.94±2.59 |
The nucleotide sequence of the fusion protein Y-L4-T is shown as SEQ ID NO. 45:
AATAGTTATGCGATTAGTGCCGCGCCGGTTGCCATACAACCCACGGGCTATACATTGGAGCGAGTGGTTATTTTGAGCCGCCATGGTGTTCGCTCGCCAACCAAACAAACACAGTTAATGAATGATGTTACCCCTGACACGTGGCCGCAATGGCCGGTCGCCGCAGGATACTTAACCCCCCGAGGTGCACAATTAGTGACATTGATGGGCGGATTCTATGGTGATTACTTCCGTAGCCAAGGGTTACTCGCAGCAGGGTGCCCAACTGACGCGGTTATTTATGCTCAGGCCGATGTTGATCAACGAACGCGTTTAACGGGGCAGGCATTCCTTGATGGAATAGCACCGGGGTGTGGACTGAAAGTACATTATCAGGCTGATTTGAAAAAAGTGGATCCGCTGTTTCATCCCGTCGACGCGGGGGTGTGTAAGTTAGATTCGACACAAACCCATAAGGCTGTTGAGGAGCGACTAGGTGGGCCATTAAGTGAACTGAGCAAACGCTATGCTAAGCCCTTTGCCCAGATGGGTGAGATTCTGAATTTTGCGGCATCTCCTTACTGTAAATCACTGCAACAGCAAGGGAAAACCTGTGATTTTGCCAACTTTGCAGCGAATAAGATCACGGTGAACAAGCCGGGGACAAAAGTCTCGCTCAGCGGACCACTGGCACTGTCATCAACCTTAGGTGAGATCTTTTTGCTACAAAATTCACAAGCGATGCCTGATGTTGCCTGGCATCGGTTAACGGGAGAAGATAATTGGATCTCGTTATTATCGTTGCACAATGCGCAATTTGATTTAATGGCAAAAACACCTTATATCGCTCGTCATAAGGGCACACCGTTGCTGCAACAGATCGAGACTGCCCTCGTCCTTCAGCGTGATGCTCAGGGGCAAACATTGCCATTATCACCTCAAACCAAAATTCTGTTCCTCGGGGGACATGATACAAACATCGCCAATATTGCTGGAATGTTGGGGGCTAACTGGCAATTACCACAGCAGCCCGATAATACCCCACCTGGGGGGGGATTGGTCTTCGAGCTATGGCAAAACCCAGATAATCATCAACGTTATGTCGCGGTGAAAATGTTCTATCAAACAATGGGCCAATTGCGAAATGCTGAGAAACTAGACCTGAAAAACAATCCGGCTGGTAGGGTCCCTGTTGCAATAGACGGTTGTGAAAATAGTGGTGATGACAAACTTTGTCAGCTTGATACCTTCCAAAAGAAAGTAGCTCAGGCGATTGAACCTGCTTGCCATATTGAAGCTGCTGCTAAGGAAGCTGCTGCTAAGGGTGGTGGTGGTTCCGGTGGTGGTGGTTCCGGTGGTGGTGGTTCCAGCGGATGTATCTCGGAGAGCAACGAAAATCAAACTGCAACGGCTTCGACCGTTCCACCGACTTCAGTGACACCCTCACAGTCTTCCACTCCCACAACCTCGACCTCGACGTACGGCCCTTCCGAAAGAACGGAGCTTAAACTTCCTTCGGTTAACTACACTCCCATCTACGTCGGCATAGAGAAAGGCTGTCCCTCCGGAAGAGTCCCGGTGAAGTTCACGTACAACCCCGGAAACAAGACCGTAAAGTCTGTCAGCCTCCGCGGGAGCTTCAACAACTGGGGAGAGTGGCCGATGGAGCTGAAGAACGGCACGTGGGAGACGACCGTCTGTCTCCGCCCTGGAAGGTATGAGTATAAGTACTTCATCAACGGCCAGTGGGTCAAGGACATGTCCGACGACGGGACGGGAAGGCCCTACGACCCCGATGCAGACGCCTATGCCCCCGATGGCTACGGGGGAAAGAACGCCGTGAGGGTAGTTGAGGGCCGCGAAGCGTTCTACGTGGAGTTCGATCCAAGAGACCCAGCCTACCTCAGCATCGCGGACAAAAGAACCGTGGTCAGGTTCGAGGCTAAGAGAGACACCGTCGAGTCTGCGGTTCTCGTTACGGATCACGGGAACTACACGATGAAGCTTCAGGTCTGGTGGGACTTCGGCGAAACCTGGCGCGCCGAGATGCCAGTTGAACCCGCTGATTATTACATTCTCGTAACCTCCTCCGACGGCGGGAAGTTTGCCGTCCTAAACACAAGCGAAAGCCCGTTCTTCCACTTTGATGGCGTTGAGGGGTTCCCCCAGCTGGAGTGGGTGAGCAACGGGATAACCTACCAGATATTCCCCGACAGGTTCAACAACGGCAATAAAAGCAACGATGCCCTAGCTTTGGATCACGACGAGCTAATTTTGAACCAGGTTAATCCAGGGCAGCCAATCCTCTCCAACTGGAGCGACCCGATAACGCCCCTCCACTGCTGCCACCAGTACTTCGGCGGCGACATAAAGGGAATAACGGAGAAGCTCGACTACCTTCAGAGCCTAGGTGTTACTATAATCTACATCAACCCGATTTTCCTCTCGGGAAGCGCCCACGGCTACGACACCTACGACTACTACCGGCTCGACCCCAAGTTCGGGACCGAGGATGAGCTGAGAGAGTTCCTCGATGAGGCCCACAGGAGGGGAATGAGGGTAATCTTCGATTTCGTGCCCAACCACTGCGGCATAGGGAATCCAGCCTTCCTCGACGTCTGGGAGAAGGGCAACGAAAGCCCATACTGGGACTGGTTCTTCGTCAAGAAGTGGCCCTTCAAGCTCGGCGATGGGAGCGCCTACGTCGGCTGGTGGGGCTTTGGGAGCCTTCCGAAGCTCAACACTGCCAACCAGGAGGTCAGGGAGTACCTGATAGGAGCGGCCCTCCACTGGATAGAGTTCGGCTTTGACGGCATTAGGGTGGATGTGCCGAACGAAGTCCTCGACCCGGGGACGTTCTTCCCGGAGCTGAGAAAGGCAGTTAAGGAGAAAAAGCCCGACGCGTACCTCGTCGGCGAGATATGGACGCTCTCCCCGGAGTGGGTGAAGGGAGACCGCTTCGACTCCCTCATGAACTACGCCCTCGGGAGGGACATCCTCCTGAACTACGCTAAGGGCCTGCTCAGCGGAGAAAGTGCAATGAAAATGATGGGACGTTACTACGCTTCCTACGGCGAGAACGTAGTTGCGATGGGCTTCAACCTCGTTGATTCGCACGACACTTCGAGGGTTCTCACTGACCTCGGTGGTGGCAAACTGGGAGACACACCGTCAAACGAGTCAATTCAGAGGCTCAAGCTCCTCTCAACGCTCCTCTATGCCCTGCCCGGAACTCCCGTCACCTTCCAGGGGGACGAGAGGGGACTGCTCGGAGACAAGGGACACTACGATGAGCAACGCTATCCGATACAGTGGGATACTGTGAACGAGGACGTCCTGAACCACTACAGGGCACTGGCGGAGCTCAGAAAAAGAGTTCCCGCATTGAGGAGCAGCGCAATGAGGTTCTACACTGCCAAAGGCGGCGTTATGGCCTTCTTCAGGGGACATCATGACGAGGTTCTCGTCGTTGCCAACAGCTGGAAGAAGCCAGCCCTACTGGAGCTTCCCGAGGGAGAGTGGAAAGTAATCTGGCCTGAGGATTTCAGCCCGGAACTGCTTCGCGGCACAGTTGAAGTGCCAGCCATAGGGATAATCATCCTTGAGCGGGGT.
The amino acid sequence of the fusion protein Y-L4-T is shown in SEQ ID NO. 46:
NSYAISAAPVAIQPTGYTLERVVILSRHGVRSPTKQTQLMNDVTPDTWPQWPVAAGYLTPRGAQLVTLMGGFYGDYFRSQGLLAAGCPTDAVIYAQADVDQRTRLTGQAFLDGIAPGCGLKVHYQADLKKVDPLFHPVDAGVCKLDSTQTHKAVEERLGGPLSELSKRYAKPFAQMGEILNFAASPYCKSLQQQGKTCDFANFAANKITVNKPGTKVSLSGPLALSSTLGEIFLLQNSQAMPDVAWHRLTGEDNWISLLSLHNAQFDLMAKTPYIARHKGTPLLQQIETALVLQRDAQGQTLPLSPQTKILFLGGHDTNIANIAGMLGANWQLPQQPDNTPPGGGLVFELWQNPDNHQRYVAVKMFYQTMGQLRNAEKLDLKNNPAGRVPVAIDGCENSGDDKLCQLDTFQKKVAQAIEPACHIEAAAKEAAAKGGGGSGGGGSGGGGSSGCISESNENQTATASTVPPTSVTPSQSSTPTTSTSTYGPSERTELKLPSVNYTPIYVGIEKGCPSGRVPVKFTYNPGNKTVKSVSLRGSFNNWGEWPMELKNGTWETTVCLRPGRYEYKYFINGQWVKDMSDDGTGRPYDPDADAYAPDGYGGKNAVRVVEGREAFYVEFDPRDPAYLSIADKRTVVRFEAKRDTVESAVLVTDHGNYTMKLQVWWDFGETWRAEMPVEPADYYILVTSSDGGKFAVLNTSESPFFHFDGVEGFPQLEWVSNGITYQIFPDRFNNGNKSNDALALDHDELILNQVNPGQPILSNWSDPITPLHCCHQYFGGDIKGITEKLDYLQSLGVTIIYINPIFLSGSAHGYDTYDYYRLDPKFGTEDELREFLDEAHRRGMRVIFDFVPNHCGIGNPAFLDVWEKGNESPYWDWFFVKKWPFKLGDGSAYVGWWGFGSLPKLNTANQEVREYLIGAALHWIEFGFDGIRVDVPNEVLDPGTFFPELRKAVKEKKPDAYLVGEIWTLSPEWVKGDRFDSLMNYALGRDILLNYAKGLLSGESAMKMMGRYYASYGENVVAMGFNLVDSHDTSRVLTDLGGGKLGDTPSNESIQRLKLLSTLLYALPGTPVTFQGDERGLLGDKGHYDEQRYPIQWDTVNEDVLNHYRALAELRKRVPALRSSAMRFYTAKGGVMAFFRGHHDEVLVVANSWKKPALLELPEGEWKVIWPEDFSPELLRGTVEVPAIGIIILERG.
EXAMPLE 3 bread baking application of phytase-pullulanase fusion protein Y-L4-T
The wheat bread making method comprises the following steps:
(1) The formula of the wheat bread is that 300g of high-gluten goldenseal wheat flour, 4.5g of high-activity yeast, 18g of sugar, 3g of salt and 180g of water are taken as raw materials, fusion protein Y-L4-T (3.25, 6.5 or 13mg of fusion protein is added to each Kg of wheat flour) or phytase YiAPPA and pullulanase TK-PUL mixed enzyme (1.15mg YiAPPA+2.1mg TK-PUL, 2.3mgYiAPPA+4.2mg TK-PUL or 4.6mgYiAPPA+8.4mg TK-PUL are added to each Kg of wheat flour) are respectively added to the raw materials, and the wheat bread without enzyme is taken as a control.
(2) The processing flow of the wheat bread comprises the steps of weighing each component according to the formula system, pouring the components into a stirring tank, stirring until the ingredients are uniform, pouring a proper amount of water, stirring at a low speed for 3min, and stirring at a high speed for 5min. The mixed dough was taken out and left to stand for 5min, after which the dough was roughly cut into 90 g/pieces. These doughs were incubated in an incubator at 37 ℃ with 90% relative humidity for 90min for proofing. The proofed dough was baked for 20min at 170℃on fire and 210℃on fire. After baking, the wheat bread was cooled at room temperature for 2 hours and then stored at 4 ℃ under conditions of 46% relative humidity.
Wheat bread prepared by adding 3.25mg of the fusion protein to each kg of wheat flour is named as wheat bread ①, wheat bread prepared by adding 6.5mg of the fusion protein to each kg of wheat flour is named as wheat bread ②, wheat bread prepared by adding 13mg of the fusion protein to each kg of wheat flour is named as wheat bread ③, wheat bread prepared by adding 1.15mg YiAPPA+2.1mg TK-PUL enzyme to each kg of wheat flour is named as wheat bread ④, wheat bread prepared by adding 2.3mg YiAPPA+4.2mg TK-PUL enzyme to each kg of wheat flour is named as wheat bread ⑤, and wheat bread prepared by adding 4.6mgYiAPPA+8.4mg TK-PUL enzyme to each kg of wheat flour is named as wheat bread ⑥.
Specific volume measurement of wheat bread: the specific volume of wheat bread on day 0 of storage was measured using the rapeseed displacement method. Taking a wheat bread sample to be measured, weighing, putting the wheat bread sample into a container with a certain volume, adding rapeseeds into the container, completely covering the bread sample, shaking up, filling the bread sample, scraping the filling agent with a ruler, taking out the bread, pouring the rapeseeds into a measuring cylinder to measure the volume, and subtracting the volume of the rapeseeds from the volume to obtain the volume of the bread. Specific volume of bread (SV) =volume of bread (V)/mass of bread (m). As shown in Table 4, the specific volume of the wheat bread was larger than that of the control group for the enzyme-treated wheat bread (wheat bread ①~⑥. RTM.) and that of the fusion protein-treated wheat bread (wheat bread ①~③. RTM.) for the enzyme-treated wheat bread (wheat bread ④~⑥. RTM.) for the enzyme-treated wheat bread, respectively, and the specific volume of the wheat bread ③ was the largest, i.e., the specific volume of the wheat bread prepared by adding 13mg of the fusion protein per Kg of wheat flour was the largest.
Table 4 specific volume of wheat bread
Texture characteristics of wheat bread were measured by slicing the breads stored on days 0,1, 3, 5 and 7 into 3cm slices, and measuring the hardness and elasticity parameters of the wheat breads on different days of storage using a texture analyzer. The results of the texture property measurement of the wheat bread are shown in Table 5, and the addition of the fusion protein and the mixed enzyme significantly reduced the hardness of the wheat bread and improved the elasticity of the wheat bread, and after the wheat bread was stored at 4 ℃, the addition of the fusion protein and the mixed enzyme also significantly improved the hardness and the elasticity of the wheat bread. The fusion protein and the mixed enzyme are very effective for improving the texture characteristics of the wheat bread, the improvement effect is in direct proportion to the enzyme dosage, and the effect of the fusion protein on improving the texture characteristics of the wheat bread is obviously better than that of the mixed enzyme under the condition of adding the same amount of enzyme. The texture characteristic measurement result of the wheat bread shows that the texture characteristic improvement degree of wheat bread ③ is the most obvious, namely the texture characteristic improvement of the wheat bread prepared by adding 13mg of fusion protein to every Kg of wheat flour is the most obvious.
Table 5 texture characteristics of wheat bread
The above embodiments are only illustrative of the preferred embodiments of the present invention and are not intended to limit the scope of the present invention, and various modifications and improvements made by those skilled in the art to the technical solutions of the present invention should fall within the protection scope defined by the claims of the present invention without departing from the design spirit of the present invention.